The Effect of Sarpogrelate & High Dose Statin on the Reduction of Coronary

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT03228238` - ANti-Oxidant in Variant Angina (ANOVA) Trial	Phase 4
	Completed	`NCT01444885` - Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina	Phase 2

See also

Status

Clinical Trial

Phase

Recruiting

NCT03228238 - ANti-Oxidant in Variant Angina (ANOVA) Trial

Phase 4

Completed

NCT01444885 - Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic Angina

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01674686
Study type	Interventional
Source	Samsung Medical Center
Contact	Hyeon-Cheol Gwon, MD,PhD
Phone	82-2-3410-3419
Email	hcgwon@skku.edu
Status	Recruiting
Phase	Phase 4
Start date	August 1, 2012
Completion date	December 31, 2018

The Effect of Sarpogrelate and High Dose Statin on the Reduction of Coronary Spasm

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms